European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019.

Publication date: Jan 09, 2020

Cutaneous melanoma (CM) is potentially the most dangerous form of skin tumor and causes 90% of skin cancer mortality. A unique collaboration of multidisciplinary experts from the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization of Research and Treatment of Cancer (EORTC) was formed to make recommendations on CM diagnosis and treatment, based on systematic literature reviews and the experts’ experience. The diagnosis of melanoma can be made clinically and shall always be confirmed through dermatoscopy. If a melanoma is suspected, a histopathological examination is required. Sequential digital dermatoscopy and full-body photography can be used in risk persons to detect the development of melanomas at an earlier stage. Where available, confocal reflectance microscopy can improve clinical diagnosis in special cases. Melanoma shall be classified according to the 8th version of the AJCC classification. Thin melanomas up to 0.8 mm tumor thickness does not require further imaging diagnostics. From stage IB onwards, examinations with lymph node sonography are recommended, but no further imaging examinations. From stage IIC whole-body examinations with CT or PET-CT in combination with brain MRI are recommended. From stage III and higher, mutation testing is recommended, particularly for BRAF V600 mutation. It is important to provide a structured follow-up to detect relapses and secondary primary melanomas as early as possible. There is no evidence to support the frequency and extent of examinations. A stage-based follow-up scheme is proposed, which, according to the experience of the guideline group, covers the minimum requirements; further studies may be considered. This guideline is valid until the end of 2021.

Open Access PDF

Garbe, C., Amaral, T., Peris, K., Hauschild, A., Arenberger, P., Bastholt, L., , Bataille, Marmol, Del, Dr’eno, B., Fargnoli, M.C., Grob, J.J., H”oller, C., Kaufmann, R., Lallas, A., Lebb’e, C., Malvehy, J., Middleton, M., Moreno-Ramirez, D., Pellacani, G., Saiag, P., Stratigos, A.J., Vieira, R., , Zalaudek, Eggermont, A.M.M., and European Dermatology Forum (EDF), the European. Association. of. Dermato-Oncology. (EADO). European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics – Update 2019. 25442. 2020 Eur J Cancer.

Concepts Keywords
8mm Dermatoscopy
AJCC RTT
BRAF Cancer
Brain Microscopy
CM Melanoma
Confocal Diagnosis melanoma
Dermatology Dermatoscopy melanoma
Dermatoscopy Secondary primary melanomas
Digital 8mm tumor
EDF Imaging
Frequency Medicine
Histopathological Pathology
Interdisciplinary Health
Lymph Node Medical specialties
Melanoma Fotofinder
Melanomas MRI
Microscopy
Mortality
MRI
Mutation
Oncology
PET CT
Photography
Reflectance
Sonography
Tumor

Semantics

Type Source Name
disease MESH melanoma
pathway KEGG Melanoma
disease MESH tumor
disease MESH skin cancer
disease MESH diagnosis
disease MESH development
disease MESH relapses

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *